Forbes William P (CIK 1314760) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-08). Recent activity: Buy HRTX (12,500 shares), Buy HRTX (3,874 shares), Buy HRTX (11,695 shares), Buy HRTX (3,875 shares), Buy HRTX (11,694 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Development Officer | Buy | 12,500 | $0 |
| 2026-04-21 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Development Officer | Buy | 3,874 | $0 |
| 2026-02-03 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Development Officer | Buy | 11,695 | $0 |
| 2026-01-20 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Development Officer | Buy | 3,875 | $0 |
| 2025-11-04 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Development Officer | Buy | 11,694 | $0 |
| 2025-10-21 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Development Officer | Buy | 3,874 | $0 |
| 2025-08-04 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Development Officer | Buy | 11,695 | $0 |
| 2025-07-22 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Development Officer | Buy | 3,874 | $0 |
| 2025-06-09 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Development Officer | Buy | 12,500 | $0 |
| 2025-05-02 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Development Officer | Buy | 11,694 | $0 |
| 2025-04-22 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Development Officer | Buy | 3,875 | $0 |
| 2025-01-22 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Development Officer | Buy | 3,874 | $0 |
Source: SEC Form 4 filings · as of 2026-06-08